A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studies.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International Journal of Molecular Epidemiology and Genetics

• Publication date

  2010-07-26

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 21532840PMCID PMC3076782
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.

  2010cited by this paper
• Rare Variants Create Synthetic Genome-Wide Associations

  2010cited by this paper
• The 1000 Genomes Project: new opportunities for research and social challenges

  2010cited by this paper
• Anti-MUC1 Antibodies and Ovarian Cancer Risk: Prospective Data from the Nurses' Health Studies

  2010cited by this paper
• A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2

  2009cited by this paper
• Genetic Polymorphisms in the Paraoxonase 1 Gene and Risk of Ovarian Epithelial Carcinoma

  2008cited by this paper
• Association of Single Nucleotide Polymorphisms in Glycosylation Genes with Risk of Epithelial Ovarian Cancer

  2008influential reference
• Consortium analysis of 7 candidate SNPs for ovarian cancer

  2008cited by this paper
• Incessant Ovulation, Mucin 1 Immunity, and Risk for Ovarian Cancer

  2007cited by this paper
• Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk.

  2005cited by this paper
• Conditions Associated with Antibodies Against the Tumor-Associated Antigen MUC1 and Their Relationship to Risk for Ovarian Cancer

  2005cited by this paper
• Assessing the probability that a positive report is false: an approach for molecular epidemiology studies.

  2004cited by this paper
• MUC1 immunobiology: from discovery to clinical applications.

  2004cited by this paper
• A comprehensive review of genetic association studies

  2002cited by this paper
• Replication validity of genetic association studies

  2001cited by this paper
• Substrate Specificities of Three Members of the Human UDP-N-Acetyl-a-D-galactosamine : Polypeptide N-Acetylgalactosaminyltransferase Family

  1997cited by this paper
• Substrate Specificities of Three Members of the Human UDP-N-Acetyl-α-d-galactosamine:Polypeptide N-Acetylgalactosaminyltransferase Family, GalNAc-T1, -T2, and -T3*

  1997cited by this paper
• Epithelial mucin genes.

  1995cited by this paper
• Structure of a tumor associated antigen containing a tandemly repeated immunodominant epitope.

  1995cited by this paper
• Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.

  1994cited by this paper
• Heterogeneity of mucin gene expression in normal and neoplastic tissues.

  1993cited by this paper

• Screening and identification of potential prognostic biomarkers in bladder urothelial carcinoma: Evidence from bioinformatics analysis

  2020cites this paper
• Evaluation of GALNT16 polymorphisms to breast cancer risk in Chinese population

  2019cites this paper
• Estimating time‐dependent ROC curves using data under prevalent sampling

  2017cites this paper
• N-acetylgalactosaminyltransferases in cancer

  2016cites this paper
• Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in Relation to Ovarian Cancer Risk and Survival

  2014cites this paper
• Targeted resequencing of the microRNAome and 3′UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer

  2014cites this paper